menu
    • menu
    [{"orgOrder":0,"company":"Elkedonia","sponsor":"Angelini Ventures","pharmaFlowCategory":"D","therapeuticArea":"Psychiatry\/Psychology","country":"U.S.A","productType":"Other Small Molecule","year":"2025","type":"Financing","leadProduct":"Undisclosed","moa":"Elk1","graph1":"Psychiatry\/Psychology","graph2":"Preclinical","graph3":"Elkedonia","amount2":0.01,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Psychiatry","amount2New":0.01,"dosageForm":"Undisclosed","sponsorNew":"Elkedonia \/ Angelini Ventures","highestDevelopmentStatusID":"4","companyTruncated":"Elkedonia \/ Angelini Ventures"}]

    Find Clinical Drug Pipeline Developments & Deals by Elkedonia

    Menu

    Elkedonia

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Elkedonia

                            France arrow
                            ACS GCI
                            Not Confirmed

                            Elkedonia

                            France arrow
                            ACS GCI
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Psychiatry/Psychology

                            Study Phase : Preclinical

                            Sponsor : Angelini Ventures

                            Deal Size : $12.9 million

                            Deal Type : Financing

                            DEALS_DEV arrow-down

                            Elkedonia Closes €11M Seed Round to Advance Neuroplastogens for Depression

                            Details : The funds will advance Elkedonia’s neuroplastogen to identify and optimize drug-like small molecule inhibitors of Elk1, a novel intracellular target previously considered to be undruggable.

                            Product Name : Undisclosed

                            Product Type : Other Small Molecule

                            Upfront Cash : Undisclosed

                            June 11, 2025

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Psychiatry/Psychology

                            Highest Development Status : Preclinical

                            Sponsor : Angelini Ventures

                            Deal Size : $12.9 million

                            Deal Type : Financing

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth